These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 18343271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transdermal methylphenidate system: old wine in a new bottle.
    Bukstein OG.
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E.
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [Abstract] [Full Text] [Related]

  • 5. Effects of application to two different skin sites on the pharmacokinetics of transdermal methylphenidate in pediatric patients with attention-deficit/hyperactivity disorder.
    González MA, Campbell D, Rubin J.
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):227-32. PubMed ID: 19519257
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methylphenidate transdermal system.
    Mays DA, Findling R.
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.
    Anderson VR, Scott LJ.
    Drugs; 2006 Dec; 66(8):1117-26. PubMed ID: 16789796
    [Abstract] [Full Text] [Related]

  • 15. Critical assessment of the methylphenidate transdermal system.
    Kowalik S, Minami H, Silva RR.
    Drugs Today (Barc); 2007 Aug; 43(8):515-27. PubMed ID: 17925883
    [Abstract] [Full Text] [Related]

  • 16. A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Findling RL, Katic A, Rubin R, Moon E, Civil R, Li Y.
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):365-75. PubMed ID: 20973707
    [Abstract] [Full Text] [Related]

  • 17. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD.
    Faraone SV, Glatt SJ, Bukstein OG, Lopez FA, Arnold LE, Findling RL.
    J Atten Disord; 2009 Jan; 12(4):308-15. PubMed ID: 18400982
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art.
    Arnold LE, Lindsay RL, López FA, Jacob SE, Biederman J, Findling RL, Ramadan Y.
    Pediatrics; 2007 Nov; 120(5):1100-6. PubMed ID: 17974748
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.